Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      FDA extends review of Roches Tecentriq by three months

      FDA extends review of Roche's Tecentriq by three months

      Medical Dialogues Bureau7 Sept 2018 10:00 AM IST
      ZURICH: Roche said the U.S. Food and Drug Administration (FDA) had extended by three months the review period for Tecentriq in combination therapy as...
      AbbVie doubles down on cancer project with biotech group Argenx

      AbbVie doubles down on cancer project with biotech group Argenx

      Medical Dialogues Bureau26 Aug 2018 9:30 AM IST
      BRUSSELS: Biotech group Argenx said U.S. pharma group AbbVie had exercised an exclusive option to develop and commercialize one of its experimental...
      Focus on 20 key brands to drive growth: GSK Pharma

      Focus on 20 key brands to drive growth: GSK Pharma

      Medical Dialogues Bureau25 Aug 2018 10:00 AM IST
      New Delhi: Drug firm Glaxo Smith Kline Pharmaceuticals said it has decided to concentrate on 20 key brands to drive growth going forward."In keeping...
      Anthem ties-up with Walmart for over-the-counter drugs

      Anthem ties-up with Walmart for over-the-counter drugs

      Medical Dialogues Bureau25 Aug 2018 9:30 AM IST
      Anthem Inc said it has partnered with Walmart Inc to launch a program in January 2019 that will allow its Medicare Advantage plan customers to...
      Lupin recalls over 11,000 bottles of hypertension drug in US

      Lupin recalls over 11,000 bottles of hypertension drug in US

      Medical Dialogues Bureau24 Aug 2018 10:15 AM IST
      New Delhi: Lupin's US arm is recalling 11,706 bottles of Lisinopril tablets, used for treating hypertension, from the American market, USFDA said.The...
      FDA declines to approve Allergan

      FDA declines to approve Allergan's Esmya

      Medical Dialogues Bureau24 Aug 2018 9:45 AM IST
      Allergan Plc said U.S. health regulators had declined to approve Esmya, its treatment for abnormal uterine bleeding in women with uterine fibroids,...
      GSK seeks bids for 4 billion dollar India sale by mid-Sept: Report

      GSK seeks bids for 4 billion dollar India sale by mid-Sept: Report

      Medical Dialogues Bureau24 Aug 2018 9:30 AM IST
      UK pharmaceutical giant GSK has requested bids by mid-September for its $4.3-billion Indian consumer-health unit, which owns the popular malted milk...
      Strides receives acceptance from USFDA for two ANDAs

      Strides receives acceptance from USFDA for two ANDAs

      Medical Dialogues Bureau22 Aug 2018 7:06 PM IST
      New Delhi: Strides Pharma Science today said its step-down wholly owned subsidiary has received acceptance from the US health regulator for two key...
      Medtronic reports about 6 pct rise in quarterly profit

      Medtronic reports about 6 pct rise in quarterly profit

      Medical Dialogues Bureau22 Aug 2018 7:06 PM IST
      Medical device maker Medtronic plc reported a near 6 per cent rise in quarterly profit on Tuesday, helped by higher sales in its cardiac and vascular...
      Torrent Pharma recalls 14 lots of Valsartan-Amlodipine-HCTZ tablets from US

      Torrent Pharma recalls 14 lots of Valsartan-Amlodipine-HCTZ tablets from US

      Medical Dialogues Bureau22 Aug 2018 7:01 PM IST
      New Delhi: Drug firm Torrent Pharmaceuticals is recalling 14 lots of tablets used for the treatment of high blood pressure and heart failure from the...
      Indian-American indicted for multi-million dollar pharma fraud scheme in US

      Indian-American indicted for multi-million dollar pharma fraud scheme in US

      Medical Dialogues Bureau19 Jun 2018 10:00 AM IST
      An Indian-American former president of a blood-testing company along with its founder has been charged in the US for allegedly engaging in a...
      Novartis touts effectiveness, safety of autoimmune drug copies

      Novartis touts effectiveness, safety of autoimmune drug copies

      Medical Dialogues Bureau19 Jun 2018 9:30 AM IST
      ZURICH: Novartis touted safety and efficacy of its biosimilar copies of Johnson & Johnson's Remicade and Amgen Inc's Enbrel, citing a study it...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok